A previously unknown connection between the immune and blood coagulation systems causes the antiphospholipid syndrome (APS). This interaction is a potential target for the development of therapies for autoimmune diseases.
A previously unknown connection between the immune and blood coagulation systems causes the antiphospholipid syndrome (APS). This interaction is a potential target for the development of therapies for autoimmune diseases.